The company
AbCellera Biologics Inc. - Common Shares
ABCL · Nasdaq
ABCL stood above a rising 150-day average in 22 of the last 52 weekly readings, including each of the last 18 weeks. It is 60.1% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 18 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $5.2M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 146 (+16)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Michael R. HaydenDirector | bought | 53,613at $10.64 | 24 Aug 2026filed 24 Aug 2026 |
| John S. MontalbanoDirector | bought | 10,000at $11.03 | 18 Aug 2026filed 18 Aug 2026 |
| Andrew BoothChief Financial Officer | bought | 37,200at $10.32 | 14 Aug 2026filed 14 Aug 2026 |
| Michael R. HaydenDirector | bought | 46,387at $10.37 | 12 Aug 2026filed 14 Aug 2026 |
| John S. MontalbanoDirector | bought | 20,000at $4.77 | 14 May 2026filed 18 May 2026 |
| Andrew BoothChief Financial Officer | bought | 42,600at $3.42 | 27 Feb 2026filed 27 Feb 2026 |
| Thermopylae Holdings Ltd.10% owner | bought | 38,000at $3.44 | 27 Feb 2026filed 2 Mar 2026 |
| Thermopylae Holdings Ltd.10% owner | bought | 177,457at $3.27 | 26 Feb 2026filed 27 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BAKER BROS. ADVISORS LPadded · filed 14 Aug 2026 | 33,012,138$259.1M | +2,736,200+9.0% |
| Capital World Investorsadded · filed 12 Aug 2026 | 13,588,349$106.7M | +227,253+1.7% |
| TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 2026 | 10,437,431$81.9M | -124,634−1.2% |
| TD Waterhouse Canada Inc.added · filed 27 Jul 2026 | 9,568,149$72.6M | +3,4900.0% |
| BANK OF AMERICA CORPadded · filed 14 Aug 2026 | 6,141,539$48.2M | +3,141,603+104.7% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCreduced · filed 13 Aug 2026 | 4,317,206$33.9M | -3,258,270−43.0% |
| ArrowMark Colorado Holdings LLCunchanged · filed 13 Aug 2026 | 4,105,095$32.2M | 00.0% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 3,805,309$29.9M | -234,927−5.8% |
| Driehaus Capital Management LLCreduced · filed 14 Aug 2026 | 2,864,729$22.5M | -1,160,050−28.8% |
| TUDOR INVESTMENT CORP ET ALreduced · filed 14 Aug 2026 | 2,063,191$16.2M | -210,298−9.3% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.